A Toll-like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV-infection.

[1]  E. Schiff,et al.  [649] CPG 10101 (ACTILON) IN COMBINATION WITH PEGYLATED INTERFERON AND/OR RIBAVIRIN IN CHRONIC HCV GENOTYPE 1 INFECTED PATIENTS WITH PRIOR RELAPSED RESPONSE: WEEK 48 DATA , 2007 .

[2]  H. Hackstein,et al.  TLR7 Ligands Induce Higher IFN-α Production in Females1 , 2006, The Journal of Immunology.

[3]  K. Bost,et al.  Sexual dimorphism in expression of receptors for bacterial lipopolysaccharides in murine macrophages: a possible mechanism for gender-based differences in endotoxic shock susceptibility. , 2006, Journal of reproductive immunology.

[4]  B. Bacon,et al.  730 Early viral response to CPG 10101, in combination with pegylated interferon and/or ribavirin, in chronic HCV genotype 1 infected patients with prior relapse response , 2006 .

[5]  V. Álvarez,et al.  The Toll‐like receptor 4 (Asp299Gly) polymorphism is a risk factor for Gram‐negative and haematogenous osteomyelitis , 2006, Clinical and experimental immunology.

[6]  M. Netea,et al.  Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection. , 2006, European cytokine network.

[7]  S. Akira,et al.  Pathogen Recognition and Innate Immunity , 2006, Cell.

[8]  Yu-Tseung Liu,et al.  Activation of anti-hepatitis C virus responses via Toll-like receptor 7. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. Plumas,et al.  Virus or TLR Agonists Induce TRAIL-Mediated Cytotoxic Activity of Plasmacytoid Dendritic Cells1 , 2006, The Journal of Immunology.

[10]  P. Gionchetti,et al.  Combined carriership of TLR9-1237C and CD14-260T alleles enhances the risk of developing chronic relapsing pouchitis. , 2005, World journal of gastroenterology.

[11]  J. Chiche,et al.  The importance of Toll-like receptor 2 polymorphisms in severe infections. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  T. Berg,et al.  Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection , 2005, Hepatology.

[13]  A. Ziegler,et al.  Common human Toll‐like receptor 9 polymorphisms and haplotypes: association with atopy and functional relevance , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[14]  U. Göbel,et al.  Heterozygous Arg753Gln Polymorphism of Human TLR-2 Impairs Immune Activation by Borrelia burgdorferi and Protects from Late Stage Lyme Disease1 , 2005, The Journal of Immunology.

[15]  G. O’Keefe,et al.  The influence of gender on human innate immunity. , 2005, Surgery.

[16]  Jörg Köhl,et al.  Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans , 2005, Nature Genetics.

[17]  R. Coppel,et al.  Genetic polymorphisms of toll-like receptor 9 influence the immune response to CpG and contribute to hyper-IgM in primary biliary cirrhosis. , 2005, Journal of autoimmunity.

[18]  F. Lammert,et al.  Transforming growth factor-β1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection , 2005 .

[19]  S. Friedman,et al.  Interleukin-6 protects hepatocytes from CCl4-mediated necrosis and apoptosis in mice by reducing MMP-2 expression. , 2005, Journal of hepatology.

[20]  J. Hunt,et al.  TLR4 and TNF-α polymorphisms are associated with an increased risk for severe sepsis following burn injury , 2004, Journal of Medical Genetics.

[21]  M. Heineman,et al.  The Effect of Testosterone on Cytokine Production in the Specific and Non‐specific Immune Response , 2004, American journal of reproductive immunology.

[22]  J. Glas,et al.  Crohn's disease is associated with a toll-like receptor-9 polymorphism. , 2004, Gastroenterology.

[23]  N. Amariglio,et al.  Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease. , 2004, The Journal of infectious diseases.

[24]  S. Akira,et al.  Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.

[25]  Shizuo Akira,et al.  Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA , 2004, Science.

[26]  J. Cauvin,et al.  Factors associated with liver steatosis and fibrosis in chronic hepatitis C patients. , 2004, Gastroenterologie clinique et biologique.

[27]  T. Zimmers,et al.  Resolving the role of IL‐6 in liver regeneration , 2003, Hepatology.

[28]  Richard J. Laws,et al.  A Common Dominant TLR5 Stop Codon Polymorphism Abolishes Flagellin Signaling and Is Associated with Susceptibility to Legionnaires' Disease , 2003, The Journal of experimental medicine.

[29]  Peter Donnelly,et al.  A comparison of bayesian methods for haplotype reconstruction from population genotype data. , 2003, American journal of human genetics.

[30]  M. Sheridan-Pereira,et al.  Sex-specific alterations in neutrophil apoptosis: the role of estradiol and progesterone. , 2003, Blood.

[31]  A. Bosserhoff,et al.  A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease. , 2003, Gastroenterology.

[32]  Jongdae Lee,et al.  Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: Activation of Toll-like receptor 7 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[33]  B. Beutler,et al.  Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[34]  B. Walker,et al.  Broad Specificity of Virus-Specific CD4+ T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection , 2002, Journal of Virology.

[35]  H. Bonkovsky,et al.  Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C. , 2002, Journal of hepatology.

[36]  S. Calvano,et al.  Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. , 2002, The Journal of infectious diseases.

[37]  A. de Silvestri,et al.  Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV‐related liver disease , 2002, Hepatology.

[38]  R. Noelle,et al.  Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod. , 2002, Cellular immunology.

[39]  B. Walker,et al.  Comprehensive Analysis of CD8+-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted Specificities , 2002, Journal of Virology.

[40]  T. Giese,et al.  Toll‐like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL‐12 , 2001 .

[41]  Z. Goodman,et al.  Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c. , 2001, Journal of hepatology.

[42]  B. Beutler,et al.  Three novel mammalian toll-like receptors: gene structure, expression, and evolution. , 2000, European cytokine network.

[43]  A. Sharp,et al.  Age- and tissue-specific variation of X chromosome inactivation ratios in normal women , 2000, Human Genetics.

[44]  S. Rose-John,et al.  Liver regeneration induced by a designer human IL‐6/ sIL‐6R fusion protein reverses severe hepatocellular injury , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  D. Purdie,et al.  Host genetic factors influence disease progression in chronic hepatitis C , 2000, Hepatology.

[46]  E. Moore,et al.  Male gender is a risk factor for major infections after surgery. , 1999, Archives of surgery.

[47]  D. Jarrossay,et al.  Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon , 1999, Nature Medicine.

[48]  P Parham,et al.  Analysis of a successful immune response against hepatitis C virus. , 1999, Immunity.

[49]  P. Scheuer,et al.  Classification of chronic viral hepatitis: a need for reassessment. , 1991, Journal of hepatology.

[50]  N. Harris,et al.  Distribution and consensus of branch point signals in eukaryotic genes: a computerized statistical analysis. , 1990, Nucleic acids research.

[51]  E. Silverman,et al.  Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies. , 2003, Genomics.

[52]  Kast Re.  Predominance of autoimmune and rheumatic diseases in females. , 1977 .